Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety study of refrigerator-stable VARIVAX in healthy 12–15 month-old infants
2004-002669-19Phase 4Completed
- Sponsor
- Sanofi Pasteur MSD
- Start
- Jun 2005
- Modality
- Prophylactic Vaccines → Vaccines & Immunotherapeutics, Live Biotherapeutic Products → Microbiome Therapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of varicella virus vaccine live in chickenpox (2 arms), sponsored by Sanofi Pasteur MSD. Started Jun 2005; status: completed.
02
Drugs
varicella virus vaccine live
03
Conditions
chickenpox
Beyond the preview
Go deeper on 2004-002669-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002669-19.